Therapy-related AML: A slip of the lip can sink a ship

Leukemia Research

Volumn 38, Issue 3, 2014, Pages 418-420

  Gale, Robert Peter ^a   Bennett, John M ^b   Hoffman, F Owen ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c Ctr Transp Anal Oak Ridge N   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; GAMMA RAYS; HUMANS; LEUKEMIA, MYELOID, ACUTE; LIKELIHOOD FUNCTIONS; UNCERTAINTY;

EID: 84894235023     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.12.023     Document Type: Letter

References (20)

1. Vardiman J.W., Thiele J., Arber D.A., et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114:937-951.
2. Morton L.M., Dores G.M., Tucker M.A., et al. Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. Blood 2013, 121(15):2996-3004.
3. Wong T.N., Ramsingh G., Young A., et al. The role of early TP53 mutations of the evolution of therapy-related AML. 55th American Society of Hematology Meeting and Exposition 2013, [Abstract].
4. Larson R.A., Wang Y., Banerjee M., et al. Prevalence of the inactivating 609C→T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 1999, 15:803-807.
5. Lan Q., Zhang L., Li G., et al. Hematotoxicity in workers exposed to low levels of benzene. Science 2004, 306:1774-1776.
6. Allan J., Smith A.G., Wheatley K., et al. Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood 2004, 104:3872-3877.
7. Welch J.S., Ley T.J., Link D.C., et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 2012, 150(July (2)):264-278. 10.1016/j.cell.2012.06.023.
8. Hsu W.L., Preston D.L., Soda M. The incidence of leukemia lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001. Radiat Res 2013, 179:361-382.
9. Kayser S., Döhner K., Krauter J., et al. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood 2011, 117:2137-2145.
10. Applebaum F.R., Gundsacker H., Head D.R., et al. Age and acute myeloid leukemia. Blood 2006, 107:3481-3485.
11. Fenaux P., Laï J.L., Quiquandon I., et al. Therapy related myelodysplastic syndrome and leukemia with no "unfavorable" cytogenetic findings have a good response to intensive chemotherapy: a report on 15 cases. Leuk Lymphoma 1991, 5:117-125.
12. Nardi V., Winkfield K.M., Ok C.Y., et al. Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms. Clin Oncol 2012, 30:2340-2347.
13. Koontz M.Z., Horning S.J., Balise R., et al. Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials. J Clin Oncol 2013, 10:592-598.
14. Praga C., Bergh J., Bliss J., et al. Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide. J Clin Oncol 2005, 23:4179-4191.
15. Koche D.C., Apostoaei A.I., Henshaw R.W., et al. Interactive Radioepidemiological Program (IREP): a web-based tool for estimating probability of causation/assigned share of radiogenic cancers. Health Phys 2008, 95:119-147. http://irep.nci.nih.gov/.
16. Land C., Gilbert E., Smith J., et al. Report of the NCI-CDC Working Group to Revise the NIH Radioepidemiological Tables 1985, NIH/NCI, Bethesda, MD. http://irep.nci.nih.gov/radrat.
17. Berrington de Gonzalez A., Apostoaei A.I., Veiga L.H., et al. RadRAT: a radiation risk assessment tool for lifetime cancer risk projection. J Radiol Prot 2012, 32:205-222.
18. Burton R.A. On being certain; Believing you are right even when you're not 2008, St Martin's Press, New York, NY.
19. Muchnik L., Aral S., Taylor S.J. Social media bias: a randomized experiment. Science 2013, 341:6146-6151.
20. Gale R.P., Opelz G. Does immune suppression increase risk of developing acute myeloid leukemia?. Leuk Res 2012, 26:422-423.